Community Health Center Efficiency: The Role of Grant Revenues in Health Center Efficiency
Complete a detailed case study analysis of the given case, using the process described in Analyzing Strategic
Health Care Cases in your course textbook Strategic Management of Health Care Organizations.
Your completed case study analysis report will include the following sections:
Executive summary
Key issues
Situational analysis
Strategy formulation
Recommendation
Implementation strategies
Benchmarks for success and contingency plans
Sample Solution
Other drugs used only in certain special situations are: ⢠Growth hormone: Prader Willi syndrome ⢠Octreotide: Hypothalamic obesity ⢠Leptin: Leptin deficiency The FDA approved a number of weight-loss medications for adults and these medications are appropriate for those â¥16 years of age with BMI â¥30kg/m2 or who have BMI â¥27 kg/m2 and at least one weight related comorbidity (e.g., hypertension or T2DM). Medication should be discontinued and the child should be re-evaluated if he/she does not have a 0.4% BMI/BMI z-score reduction after taking full dose of anti-obesity medication for 12 weeks. BARIATRIC SURGERY Pre-requisites (Endocrine Society recommendations): 1) Adolescent Tanner 4-5, and final/near final adult height. 2) BMI 40kg/m2 or BMI >35kg/m2 and significant extreme comorbidities. 3) Extreme obesity and co-morbidities persist despite lifestyle modification, with or without trial of pharmacotherapy. 4) Psychological evaluation confirms stability & competence of the family 5) Patient demonstrates ability to adhere to the principles of healthy dietary and activity habits. 6) Access to experienced surgeon in medical center.>
Other drugs used only in certain special situations are: ⢠Growth hormone: Prader Willi syndrome ⢠Octreotide: Hypothalamic obesity ⢠Leptin: Leptin deficiency The FDA approved a number of weight-loss medications for adults and these medications are appropriate for those â¥16 years of age with BMI â¥30kg/m2 or who have BMI â¥27 kg/m2 and at least one weight related comorbidity (e.g., hypertension or T2DM). Medication should be discontinued and the child should be re-evaluated if he/she does not have a 0.4% BMI/BMI z-score reduction after taking full dose of anti-obesity medication for 12 weeks. BARIATRIC SURGERY Pre-requisites (Endocrine Society recommendations): 1) Adolescent Tanner 4-5, and final/near final adult height. 2) BMI 40kg/m2 or BMI >35kg/m2 and significant extreme comorbidities. 3) Extreme obesity and co-morbidities persist despite lifestyle modification, with or without trial of pharmacotherapy. 4) Psychological evaluation confirms stability & competence of the family 5) Patient demonstrates ability to adhere to the principles of healthy dietary and activity habits. 6) Access to experienced surgeon in medical center.>
